Scientists Validate That COVID-19 Causes Microvascular Alteration In Study Using Nailfold Capillaroscopy
COVID-19 News - Microvascular Alteration May 30, 2023 10 months, 2 weeks, 5 days, 4 hours, 54 minutes ago
COVID-19 News: In a new collaborative study conducted by renowned institutions including the University of Trieste, University of Milan, University of Manchester & Salford Royal NHS Foundation Trust, Manchester, Università del Piemonte Orientale (UPO), and Azienda Ospedaliero-Universitaria, researchers have validated that COVID-19 has a direct correlation with microvascular alterations.
.jpg)
Nailfold video capillaroscopy images (×200) in four COVID-19 survivors (A–D) with reduced
number of capillaries (black bar is one millimeter long) and nonspecific abnormalities
(tortuous and crossing capillaries). Images by Stefano Tavano, Luca Ruggero, and Lucrezia Mondini.
The study, which utilized nailfold capillaroscopy, has significant implications for the understanding and management of the disease.
COVID-19, caused by the SARS-CoV-2 virus, has wreaked havoc across the globe since its emergence in Wuhan, China, in 2019. While the disease primarily affects the respiratory system, scientists have increasingly recognized its systemic manifestations, affecting various organs and bodily systems as documented in various studies and
COVID-19 News reports.
In an effort to shed light on the complex pathogenesis of COVID-19, the study team turned to nailfold capillaroscopy, a safe, noninvasive method for evaluating microcirculation alterations.
Nailfold video capillaroscopy (NVC) has been widely used since the 1990s in the diagnosis and assessment of rheumatologic diseases, particularly systemic sclerosis. However, recent studies have extended its applications to other conditions involving endothelial dysfunction. Given the emerging evidence of endothelial involvement in COVID-19, the study team saw potential in employing NVC to analyze microcirculatory changes in patients at different stages of the disease.
It was found that in the acute phase of SARS-CoV-2 infection, NVC revealed visible microcirculatory changes, such as enlarged capillaries, edema, microhemorrhages, and thromboembolic phenomena. These alterations are reversible and tend to disappear as patients recover from the acute phase. However, in the post-infectious phase, a reduction in capillary density has been commonly observed. This alteration may persist over time and could potentially be linked to the development of long-term symptoms in some patients.
The implications from the current study extend beyond the acute phase of COVID-19. As researchers delve deeper into the long-term effects of the disease, NVC offers a noninvasive and easily applicable method for monitoring the recovery phase and evaluating the effectiveness of therapeutic and rehabilitation approaches. It may also serve as a valuable tool in identifying and managing Long COVID, a syndrome characterized by persistent symptoms following the resolution of the acute infection.
While specific patterns of microcirculation alterations related to COVID-19 have yet to be established, the study demonstrates statistically significant changes detectable by NVC. As researchers continue to investigate these alt
erations over time, they aim to refine their understanding of the disease and its long-term implications. Moreover, with the availability of refined pharmaceutical protocols, future studies could explore the potential for more aggressive anti-inflammatory therapies to ameliorate these microcirculatory alterations.
These findings highlight the significant impact of COVID-19 on microvascular health and provide valuable insights into disease progression and complications.
The findings from NVC studies also have implications for predicting patient outcomes and guiding clinical decision-making. For ICU patients with severe SARS-CoV-2 pneumonia, NVC could serve as a safe and applicable method to assess their prognosis. Evaluating microcirculation impairment through NVC in the early stages of the disease may help predict the course of the infection and guide the intensity of care required. Furthermore, by analyzing the correlation between microcirculatory alterations visible by NVC and the development of serious complications, such as pulmonary embolism and acute respiratory distress syndrome (ARDS), clinicians can better anticipate and manage these complications and make more informed therapeutic decisions.
The validation of COVID-19's impact on microvascular health through NVC represents a significant breakthrough in our understanding of the disease. The study's findings underscore the need for continued research to uncover the nuances of microcirculatory alterations throughout the different stages of COVID-19. By incorporating NVC into clinical practice, healthcare professionals can enhance their ability to manage patients effectively, both during and after the acute phase of the disease. As we navigate the ongoing pandemic, these insights pave the way for more targeted interventions and personalized treatment approaches for patients with COVID-19. The ability to detect microvascular alterations using nailfold video capillaroscopy (NVC) provides valuable information about the disease progression and potential complications. The use of NVC holds great potential in improving patient outcomes and shaping the future of personalized medicine.
The study findings were published in the peer reviewed journal: Diagnostics.
https://www.mdpi.com/2075-4418/13/11/1905
For the latest
COVID-19 News, keep on logging to Thailand Medical News.
Share
Tweet
Share
